EVOLYSSE™ FORM, 2025
Used FACE-Q Nasolabial Folds scale as a secondary effectiveness endpoint.
To view the label claim, click HERE.
JUVÉDERM® VOLUMA® XC, 2024
Used FACE-Q Aesthetics Satisfaction with Face Overall and Temples scales as a Secondary Endpoint.
To view the label claim, click HERE.
BELOTERO BALANCE® (+), 2019 and 2023
Used FACE-Q Appraisal of Nasolabial Folds and Aging VAS (2019) and Satisfaction with Eyes and Appraisal of Lower Eyelids (2023) as effectiveness endpoints.
To view the label claim, click HERE.
RADIESSE® (+), 2021
Used FACE-Q Satisfaction with Lower Face and Jawline scale as a secondary effectiveness endpoint.
To view the label claim, click HERE.
RHA® Redensity™, 2021
Used FACE-Q Appraisal of Lower Eyelids scale.
To view the label claim, click HERE.
Restylane® Defyne, 2021
Used FACE-Q Aesthetics Satisfaction with Chin scale as a Secondary Endpoint.
To view the label claim, click HERE.
Restylane® Kysse, 2020
Used FACE-Q Aesthetics Satisfaction with Lips and Appraisal of Lines: Lips scales as a Secondary Endpoint.
To view the label claim, click HERE.
JUVÉDERM® VOLUMA™ XC, 2020
Used FACE-Q Aesthetics Satisfaction with Chin scale as a Secondary Endpoint.
To view the label claim, click HERE.
JUVÉDERM VOLLURE™ XC, 2017
Used FACE-Q Aesthetics Appraisal of Lines: Nasolabial folds and Recovery Early Symptoms scales as a Secondary Endpoint.
To view the label claim, click HERE.
JUVÉDERM VOLBELLA® XC, 2017
Used FACE-Q Aesthetics Satisfaction with Lips, Appraisal of Lines: Lips, and Early Life Impact of Treatment scales as a Secondary Endpoint.
To view the label claim, click HERE.





